(Q37809855)

23 August 2017

title

Estrogen-free oral hormonal contraception: benefits of the progestin-only pill (English)

1 reference

23 August 2017

1 reference

Nilson Roberto de Melo

series ordinal

1

1 reference

23 August 2017

publication date

1 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

721-735

1 reference

Ovulation incidence with oral contraceptives: a literature review

23 August 2017

cites work

1 reference

Oral contraceptive health benefits: perception versus reality

21 January 2018

1 reference

Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study

21 January 2018

1 reference

Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.

21 January 2018

1 reference

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

21 January 2018

1 reference

Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms

21 January 2018

1 reference

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

21 January 2018

1 reference

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

The changing scene--an unnecessary pill crisis

21 January 2018

1 reference

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use.

21 January 2018

1 reference

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

21 January 2018

1 reference

The differential risk of oral contraceptives: the impact of full exposure history

21 January 2018

1 reference

The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.

21 January 2018

1 reference

Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias.

21 January 2018

1 reference

Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database

21 January 2018

1 reference

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

21 January 2018

1 reference

Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis

21 January 2018

1 reference

Cardiovascular risk factors and venous thromboembolism: a meta-analysis

21 January 2018

1 reference

Contraceptive hormone use and cardiovascular disease

21 January 2018

1 reference

Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies

21 January 2018

1 reference

Oral contraceptives use and the risk of myocardial infarction: a meta-analysis

21 January 2018

1 reference

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

21 January 2018

1 reference

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

21 January 2018

1 reference

Oral contraceptives and myocardial infarction: results of the MICA case-control study

21 January 2018

1 reference

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

Ischemic stroke risk with oral contraceptives: A meta-analysis

21 January 2018

1 reference

Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence

21 January 2018

1 reference

Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

21 January 2018

1 reference

Migraine with and without aura and risk for cardiovascular disease

21 January 2018

1 reference

Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Combined oral contraceptive use among women with hypertension: a systematic review

21 January 2018

1 reference

Combined oral contraceptives, smoking, and cardiovascular risk

21 January 2018

1 reference

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

21 January 2018

1 reference

Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism

21 January 2018

1 reference

Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: the Telecom study

21 January 2018

1 reference

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus

21 January 2018

1 reference

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

21 January 2018

1 reference

The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters

21 January 2018

1 reference

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

21 January 2018

1 reference

Contraception in perimenopausal women with diabetes mellitus.

21 January 2018

1 reference

The epidemiology of endometrial cancer in young women

21 January 2018

1 reference

A case-control study of cancer of the endometrium

21 January 2018

1 reference

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis

21 January 2018

1 reference

Oral contraceptives and the risk of breast cancer.

21 January 2018

1 reference

Combined hormonal versus nonhormonal versus progestin-only contraception in lactation

21 January 2018

1 reference

20 µg versus >20 µg estrogen combined oral contraceptives for contraception

21 January 2018

1 reference

Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review

21 January 2018

1 reference

21 January 2018

Hormone-related headache

1 reference

Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan

21 January 2018

1 reference

Oral contraceptive discontinuation: do side effects matter?

21 January 2018

1 reference

Primary dysmenorrhea: advances in pathogenesis and management

21 January 2018

1 reference

Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives.

21 January 2018

1 reference

Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive

21 January 2018

1 reference

Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception

21 January 2018

1 reference

Desogestrel-only pill (Cerazette).

21 January 2018

1 reference

Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake

21 January 2018

1 reference

21 January 2018

Hormonal contraception

1 reference

Post-marketing surveillance of Norplant((R)) contraceptive implants: II. Non-reproductive health(1).

21 January 2018

1 reference

Effects of desogestrel on carbohydrate metabolism

21 January 2018

1 reference

Progestin-only pills for contraception

21 January 2018

1 reference

Bleeding problems and progestogen-only contraception

21 January 2018

1 reference

Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom

21 January 2018

1 reference

Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate

21 January 2018

1 reference

Risk of acute myocardial infarction and low-dose combined oral contraceptives

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.10.36

1 reference

23 August 2017

1 reference